GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Level Bio AB (XSAT:LEVBIO) » Definitions » Total Equity

Level Bio AB (XSAT:LEVBIO) Total Equity : kr7.96 Mil (As of Mar. 2024)


View and export this data going back to 2006. Start your Free Trial

What is Level Bio AB Total Equity?

Level Bio AB's total equity for the quarter that ended in Mar. 2024 was kr7.96 Mil.

This is Residual interest, including minority interest, that remains in the assets of the enterprise after deducting its liabilities. Equity is increased by owners’ investments and by comprehensive income, and it is reduced by distributions to the owners.

Level Bio AB Total Equity Historical Data

The historical data trend for Level Bio AB's Total Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Level Bio AB Total Equity Chart

Level Bio AB Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Total Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.49 3.00 22.11 19.89 10.42

Level Bio AB Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Total Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 19.34 16.97 14.68 10.42 7.96

Level Bio AB Total Equity Calculation

Total Equity and Total Liabilities are the two components for Total Assets.

Level Bio AB's Total Equity for the fiscal year that ended in Dec. 2023 is calculated as

Total Equity=Total Assets(Q: Dec. 2023 )-Total Liabilities(Q: Dec. 2023 )
=19.093-8.678
=10.42

Level Bio AB's Total Equity for the quarter that ended in Mar. 2024 is calculated as

Total Equity=Total Assets(Q: Mar. 2024 )-Total Liabilities(Q: Mar. 2024 )
=15.737-7.777
=7.96

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Level Bio AB Total Equity Related Terms

Thank you for viewing the detailed overview of Level Bio AB's Total Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Level Bio AB (XSAT:LEVBIO) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Level Bio AB (XSAT:LEVBIO) » Definitions » Total Equity
Comparable Companies
OSTO:PROGEN XSAT:SPERM OSTO:IMMNOV NGM:ATANA XSAT:GEAN XSAT:CALMA B OSTO:AROC OSTO:SENZA TMO DHR SHSE:603259 IDXX IQV A XSWX:LONN MTD ICLR ILMN LH DGX
Traded in Other Exchanges
LEVBIO:Sweden
Address
Vastra Finnbodavagen 4B, Nacka, Stockholm, SWE, 131 30
Website
http://www.alphahelix.com
AlphaHelix Molecular Diagnostics AB develops, manufactures, and markets products for DNA-identification and quantitation in molecular diagnostics and life science research. Its product inlcude Rob, BugScreener MRSA, and aAmp. The company applications inlcude Diagnostics, PCR and Liquid handling.

Level Bio AB (XSAT:LEVBIO) Headlines

No Headlines